Your browser doesn't support javascript.
loading
An Uncommon Side Effect of Rivaroxaban: A Drug-Induced Liver Injury.
Karki, Bhesh R; Jasaraj, Ranjit B; Jha, Suman K; Maisuradze, Nodari; Yu, Qi.
Afiliação
  • Karki BR; Internal Medicine, State University of New York (SUNY) Downstate Health Sciences University, New York City, USA.
  • Jasaraj RB; Internal Medicine, Mount Sinai Hospital Medical Center of Chicago, Chicago, USA.
  • Jha SK; Family Medicine, University of North Dakota, Fargo, USA.
  • Maisuradze N; Internal Medicine, State University of New York (SUNY) Downstate Health Sciences University, New York City, USA.
  • Yu Q; Gastroenterology and Hepatology, State University of New York (SUNY) Downstate Health Sciences University, New York City, USA.
Cureus ; 15(9): e45949, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37885502
ABSTRACT
Rivaroxaban is rarely associated with drug-induced liver injury (DILI). A 57-year-old male was sent to the emergency room from an endocrine clinic for a presyncope evaluation. His exam was non-focal, and his laboratory work was remarkable for the hepatocellular pattern of liver injury. Upon detailed assessment, he was found to have DILI due to rivaroxaban. The liver function tests improved after its discontinuation. This case emphasizes the need for early recognition and timely intervention to prevent further hepatotoxicity from the culprit drug.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article